Literature DB >> 19380356

Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.

Raewyn M Seaberg1, Spiro Eski, Jeremy L Freeman.   

Abstract

OBJECTIVE: To determine whether previous radiation exposure to the head and neck is related to less favorable pathologic and clinical outcome in patients after surgical management of thyroid cancer.
DESIGN: Retrospective chart review.
SETTING: Academic teaching hospital (referral center). PATIENTS: All patients with diagnosed thyroid cancer who had been exposed to radiation before surgical treatment were retrospectively identified from the thyroid cancer database at our institution (1963-2007). One hundred twenty-five patients (95 women and 30 men) were included. Inclusion criteria included surgical treatment for thyroid cancer and a history of exposure to radiation at least 3 years before diagnosis of the disease. MAIN OUTCOME MEASURES: Pathologic features and data related to disease recurrence, distant metastasis, and survival.
RESULTS: Mean (range) age at first exposure to radiation was 19.4 (1-65) years, and mean lag time to diagnosis of disease was 28.7 (3-60) years. Patients were treated surgically with either total or near-total thyroidectomy (83%) or partial or subtotal thyroidectomy (17%). Pathologic diagnoses included 111 papillary carcinomas (89%). Sixty-three percent of patients had multifocal disease, 12% had lymphovascular tumor invasion, and 26% had direct extrathyroid extension of disease. Twenty-five percent of patients had metastases to cervical lymph nodes, and 9% had distant metastases. Sixteen percent of patients experienced local recurrence of disease. At last follow-up, 86% of patients were alive and free of disease, 8% were alive with disease, 4% had died of thyroid cancer, and 2% had died of an unrelated cause. Compared with other patients with thyroid cancer, this radiation-exposed cohort was more likely to undergo total thyroidectomy, multiple operative procedures, and external radiotherapy. A higher percentage had multifocal disease, extrathyroid extension, stage IV disease, and distant metastases. At follow-up, fewer patients were free of disease, and more patients had died of thyroid disease.
CONCLUSION: Patients who have been exposed to radiation have more aggressive disease and worse clinical outcome than other patients with thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380356     DOI: 10.1001/archoto.2009.13

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  11 in total

Review 1.  Exposing the thyroid to radiation: a review of its current extent, risks, and implications.

Authors:  Bridget Sinnott; Elaine Ron; Arthur B Schneider
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

2.  Clinical presentations of thyroid cancer patients with multiple primary cancers.

Authors:  J D Lin; K J Lin; T C Chao; C Hseuh; N M Tsang; B Y Huang
Journal:  J Endocrinol Invest       Date:  2011-05-24       Impact factor: 4.256

3.  Evaluation based on Monte Carlo simulation of lifetime attributable risk of cancer after neck X-ray radiography.

Authors:  Deoknam Seo; Seonggyu Han; Kie Hwan Kim; Jungsu Kim; Kyung Park; Hyunjong Lim; Jungmin Kim
Journal:  Radiol Med       Date:  2015-04-29       Impact factor: 3.469

Review 4.  Occult thyroid carcinoma.

Authors:  J Boucek; J Kastner; J Skrivan; E Grosso; B Gibelli; G Giugliano; J Betka
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

5.  Response to the commentary letter entitled 'Diagnostic radiography and thyroid cancer - causation or simply an association?' to our article entitled 'Diagnostic radiography exposure increases the risk for thyroid microcarcinoma: a population-based case-control study' that was published in the European Journal of Cancer Prevention 2015; 24(5):439-446.

Authors:  Yawei Zhang; Huang Huang; Jason Sandler; Robert Udelsman
Journal:  Eur J Cancer Prev       Date:  2016-11       Impact factor: 2.497

Review 6.  Molecular imaging in thyroid cancer.

Authors:  T F Heston; R L Wahl
Journal:  Cancer Imaging       Date:  2010-01-20       Impact factor: 3.909

7.  BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.

Authors:  Jason D Prescott; Peter M Sadow; Richard A Hodin; Long Phi Le; Randall D Gaz; Gregory W Randolph; Antonia E Stephen; Sareh Parangi; Gilbert H Daniels; Carrie C Lubitz
Journal:  Surgery       Date:  2012-12       Impact factor: 3.982

8.  Age greater than 60 years portends a worse prognosis in patients with papillary thyroid cancer: should there be three age categories for staging?

Authors:  Rondi M Kauffmann; J Blair Hamner; Philip H G Ituarte; John H Yim
Journal:  BMC Cancer       Date:  2018-03-22       Impact factor: 4.430

9.  Thyroid cancer mortality is higher in Filipinos in the United States: An analysis using national mortality records from 2003 through 2012.

Authors:  Michelle-Linh T Nguyen; Jiaqi Hu; Katherine G Hastings; Eric J Daza; Mark R Cullen; Lisa A Orloff; Latha P Palaniappan
Journal:  Cancer       Date:  2017-09-07       Impact factor: 6.921

10.  Multistage carcinogenesis and the incidence of thyroid cancer in the US by sex, race, stage and histology.

Authors:  Rafael Meza; Joanne T Chang
Journal:  BMC Public Health       Date:  2015-08-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.